node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
BGLAP | BMP2 | ENSBTAP00000047703 | ENSBTAP00000006739 | Osteocalcin; Constitutes 1-2% of the total bone protein. It binds strongly to apatite and calcium. | Bone morphogenetic protein 2. | 0.891 |
BGLAP | BMP4 | ENSBTAP00000047703 | ENSBTAP00000004992 | Osteocalcin; Constitutes 1-2% of the total bone protein. It binds strongly to apatite and calcium. | Bone morphogenetic protein 4; Induces cartilage and bone formation. Acts in concert with PTHLH/PTHRP to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction (By similarity). | 0.696 |
BGLAP | DLX5 | ENSBTAP00000047703 | ENSBTAP00000024811 | Osteocalcin; Constitutes 1-2% of the total bone protein. It binds strongly to apatite and calcium. | Distal-less homeobox 5. | 0.824 |
BGLAP | LEF1 | ENSBTAP00000047703 | ENSBTAP00000061494 | Osteocalcin; Constitutes 1-2% of the total bone protein. It binds strongly to apatite and calcium. | Lymphoid enhancer binding factor 1. | 0.410 |
BGLAP | MSX1 | ENSBTAP00000047703 | ENSBTAP00000014447 | Osteocalcin; Constitutes 1-2% of the total bone protein. It binds strongly to apatite and calcium. | Homeobox protein MSX-1; Acts as a transcriptional repressor. May play a role in limb- pattern formation. Acts in cranofacial development and specifically in odontogenesis (By similarity). | 0.463 |
BGLAP | MSX2 | ENSBTAP00000047703 | ENSBTAP00000018417 | Osteocalcin; Constitutes 1-2% of the total bone protein. It binds strongly to apatite and calcium. | Homeobox protein MSX-2; Acts as a transcriptional regulator in bone development. Represses the ALPL promoter activity and antagonizes the stimulatory effect of DLX5 on ALPL expression during osteoblast differentiation. Probable morphogenetic role. May play a role in limb-pattern formation. In osteoblasts, suppresses transcription driven by the osteocalcin FGF response element (OCFRE). Binds to the homeodomain-response element of the ALPL promoter (By similarity). | 0.736 |
BGLAP | RUNX2 | ENSBTAP00000047703 | ENSBTAP00000072258 | Osteocalcin; Constitutes 1-2% of the total bone protein. It binds strongly to apatite and calcium. | Runt-related transcription factor; Forms the heterodimeric complex core-binding factor (CBF) with CBFB. RUNX members modulate the transcription of their target genes through recognizing the core consensus binding sequence 5'- TGTGGT-3', or very rarely, 5'-TGCGGT-3', within their regulatory regions via their runt domain, while CBFB is a non-DNA-binding regulatory subunit that allosterically enhances the sequence-specific DNA-binding capacity of RUNX. | 0.939 |
BGLAP | SOX9 | ENSBTAP00000047703 | ENSBTAP00000073259 | Osteocalcin; Constitutes 1-2% of the total bone protein. It binds strongly to apatite and calcium. | SRY-box transcription factor 9. | 0.749 |
BGLAP | SPP1 | ENSBTAP00000047703 | ENSBTAP00000062863 | Osteocalcin; Constitutes 1-2% of the total bone protein. It binds strongly to apatite and calcium. | Osteopontin; Binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix. Probably important to cell-matrix interaction. | 0.962 |
BMP2 | BGLAP | ENSBTAP00000006739 | ENSBTAP00000047703 | Bone morphogenetic protein 2. | Osteocalcin; Constitutes 1-2% of the total bone protein. It binds strongly to apatite and calcium. | 0.891 |
BMP2 | BMP4 | ENSBTAP00000006739 | ENSBTAP00000004992 | Bone morphogenetic protein 2. | Bone morphogenetic protein 4; Induces cartilage and bone formation. Acts in concert with PTHLH/PTHRP to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction (By similarity). | 0.904 |
BMP2 | DLX5 | ENSBTAP00000006739 | ENSBTAP00000024811 | Bone morphogenetic protein 2. | Distal-less homeobox 5. | 0.674 |
BMP2 | MSX1 | ENSBTAP00000006739 | ENSBTAP00000014447 | Bone morphogenetic protein 2. | Homeobox protein MSX-1; Acts as a transcriptional repressor. May play a role in limb- pattern formation. Acts in cranofacial development and specifically in odontogenesis (By similarity). | 0.443 |
BMP2 | MSX2 | ENSBTAP00000006739 | ENSBTAP00000018417 | Bone morphogenetic protein 2. | Homeobox protein MSX-2; Acts as a transcriptional regulator in bone development. Represses the ALPL promoter activity and antagonizes the stimulatory effect of DLX5 on ALPL expression during osteoblast differentiation. Probable morphogenetic role. May play a role in limb-pattern formation. In osteoblasts, suppresses transcription driven by the osteocalcin FGF response element (OCFRE). Binds to the homeodomain-response element of the ALPL promoter (By similarity). | 0.710 |
BMP2 | RUNX2 | ENSBTAP00000006739 | ENSBTAP00000072258 | Bone morphogenetic protein 2. | Runt-related transcription factor; Forms the heterodimeric complex core-binding factor (CBF) with CBFB. RUNX members modulate the transcription of their target genes through recognizing the core consensus binding sequence 5'- TGTGGT-3', or very rarely, 5'-TGCGGT-3', within their regulatory regions via their runt domain, while CBFB is a non-DNA-binding regulatory subunit that allosterically enhances the sequence-specific DNA-binding capacity of RUNX. | 0.935 |
BMP2 | SOX9 | ENSBTAP00000006739 | ENSBTAP00000073259 | Bone morphogenetic protein 2. | SRY-box transcription factor 9. | 0.758 |
BMP2 | SPP1 | ENSBTAP00000006739 | ENSBTAP00000062863 | Bone morphogenetic protein 2. | Osteopontin; Binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix. Probably important to cell-matrix interaction. | 0.923 |
BMP4 | BGLAP | ENSBTAP00000004992 | ENSBTAP00000047703 | Bone morphogenetic protein 4; Induces cartilage and bone formation. Acts in concert with PTHLH/PTHRP to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction (By similarity). | Osteocalcin; Constitutes 1-2% of the total bone protein. It binds strongly to apatite and calcium. | 0.696 |
BMP4 | BMP2 | ENSBTAP00000004992 | ENSBTAP00000006739 | Bone morphogenetic protein 4; Induces cartilage and bone formation. Acts in concert with PTHLH/PTHRP to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction (By similarity). | Bone morphogenetic protein 2. | 0.904 |
BMP4 | DLX5 | ENSBTAP00000004992 | ENSBTAP00000024811 | Bone morphogenetic protein 4; Induces cartilage and bone formation. Acts in concert with PTHLH/PTHRP to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction (By similarity). | Distal-less homeobox 5. | 0.631 |